drugset / Trial / NCT03509025

Follow-up Study for Participants Jointstem Clinical Trial

NCT03509025

Phase 2 Completed 11 enrolled R-Bio
NaSingle-groupOpen-labelTreatment

Summary

This study is a long term follow-up study to investigate the safety of autologous transplantation of Adipose Tissue derived Mesenchymal stem cells (MSCs) in patient with Knee Osteoarthritis.

Timeline

Start
2017-02-08
Primary completion
2020-12-09
Completion
2020-12-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous adipose-derived mesenchymal stem cells Cell therapy

Indications